Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Exa Corp (EXA): This Fund Now Holds a Big Position

Featured tickers:  Exa Corp (NASDAQ:EXA), Facebook Inc (NASDAQ:FB)

Discovery Group is a hedge fund which specializes in investing in micro-capitalized stocks using fundamental valuation techniques. It was founded by Daniel J. Donoghue and Michael R Murphy in 2002, who are still the managing partners of the fund.

Recently the fund filed a 13G form with the SEC, disclosing a substantial holding in Exa Corp (NASDAQ:EXA). The fund now holds 703,383 shares of EXA, worth about $5.9 million. We will now take a quick look at Exa Corp (NASDAQ:EXA).

Why this is worth doing

Retail investors can benefit from watching hedge fund sentiment. The top holdings of the best money managers can beat the market by as much as 18 percentage points a year. Discover the details of this strategy.

A quick look

Exa Corp (NASDAQ:EXA) provides simulation software and related services for vehicle manufacturers. The Company’s primary product, PowerFLOW, aims to provide engineers and designers an alternative to physical prototyping. The Company is primarily focused on the ground transportation market, but is gradually attempting to expand to other industries including aerospace, oil and gas production, chemical processing, architecture, engineering and construction, power generation, biomedical and electronics.

Facebook Inc. (FB)

More than 90 car manufacturers use the PowerFLOW product, and these manufacturers include 13 of the largest producers. The company generated its first commercial revenue in 1994, and increased it for 18 consecutive years. The IPO for the company took place in June 2012, and was much watched by market participants as it was one of the first IPOs to launch on the Nasdaq after the debut of Facebook Inc (NASDAQ:FB), which was troubled by a number of technical issues on the exchange.

The company recently posted disappointing quarterly earnings of 1 cent per share; analysts were expecting 3 cents per share, although revenue did beat estimates at $13.10 million. As a consequence of the earning miss, many analysts have cut their price targets for the stock, with Cannacord Genuity, for example, lowering their target to $10.50 from $12.50.

As of this writing, EXA trades at $8.34 a share, having been in a downtrend for several months – the stock hit its 52-week high of $13.40 last October.

Disclosure: none

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!